Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
IHH Singapore Honoured for Corporate Giving Excellence
Gleneagles JPMC Strengthens Cross-Border Healthcare Collaboration
East Meets West in Holistic Hypertension Care by Parkway Shenton
Parkway Shenton and Eu Yan Sang have deepened their collaboration with the launch of their Integrative Clinical Care Protocol for Hypertension, an innovative collaboration combining Western and traditional Chinese medicine (TCM).
From Patient to Pillar of Support: A Cancer Survivor’s Journey at Acibadem Kent Hospital
When Neslihan Ergin was diagnosed with breast cancer in early 2020, she never imagined that the hospital where she received treatment would one day become her workplace and her new purpose.
IHH Wins ASEAN Best BCM Organisation of the Year Award 2025
On 21 July 2025, IHH Healthcare was awarded the ASEAN Best BCM Organisation of the Year Award 2025, recognising our excellence in resilience and business continuity management (BCM).
Pantai Hospital Ipoh Achieves Surgical Milestone with First Minimally Invasive Thymectomy
With the successful completion of its first minimally invasive surgical procedure to remove the thymus gland, Pantai Hospital Ipoh has taken a major step forward in patient-centred care.
